The results of the International Ivermectin Project Team were finally published this week in Open Forum Infectious Diseases, and although they’re positive, they haven’t escaped criticism, and most researchers still want results from a randomized controlled trial. In addition, many studies included in the analysis were not peer reviewed, which was a limitation, and studies varied widely in terms of dosage, treatment duration, and inclusion criteria.